Self-testing and home treatment initiation triples uptake of HIV treatment in Malawi
Sofosbuvir plus ribavirin works well for hard-to-treat inner-city hepatitis C patients
AbbVie interferon-free combinations cure most newly treated hepatitis C patients
Are we underestimating the proportion of virally-suppressed patients in the US?
Lopinavir/ritonavir equivalent to nevirapine in Ugandan children
Gene therapy studies show potential for HIV control without drugs
Adding telaprevir improves acute hepatitis C treatment for HIV-positive men
Simeprevir & sofosbuvir demonstrates good early cure rate with or without ribavirin
Malawi achieves seven-fold increase in ART for pregnant and breastfeeding women
Routine viral load monitoring almost halves risk of virologic failure in 18-month Kenyan study
Faldaprevir ups interferon response in HIV/HCV co-infection
Simeprevir pushes HCV cure rate above 75% for HIV/HCV co-infection
Contraceptive injections and HIV infection risk – a public health conundrum
New integrase inhibitor dolutegravir helps treatment-experienced people on failing therapy
Second-line NRTI-sparing regimen proves equally effective for resource-limited settings
Can people with resistant HIV omit NRTIs when switching from a failing regimen?
New pro-drug tenofovir alafenamide appears equally effective but better tolerated
